Abstracts and Posters Archives - ClearNote Health

Skip to the content

Our Story
- About Us
- Leadership Team
- FAQs
- Careers
Our Approach
Our Products
Our News
Contact Us
Order Test

Our Story
- About Us
- Leadership Team
- FAQs
- Careers
Our Approach
Our Products
Our News
Contact Us
Order Test

Our Story
- About Us
- Leadership Team
- FAQs
- Careers
Our Approach
Our Products
Our News
Contact Us
Order Test

HomeAbstracts and Posters

Detection of High-Risk Pancreatic Cysts using Avantect™ blood-based test

Meet Us at ASCO 2026

ClearNote Health

ClearNote Health Secures $52 Million in Series D Financing and Strengthens Leadership Team to Accelerate Growth in Early Cancer Detection

ClearNote Health

Follow us

Empowering early cancer detection.

Company

About Us
Leadership Team
Our News
Careers
Contact Us

Solutions

Avantect Pancreatic Cancer Test
Avantect Ovarian Cancer Test
Virtuoso Epigenomics Platform

Stay Informed

Get the latest research and announcements from ClearNote Health. Follow us:

Important information:
The Virtuoso platform is for research use only. Not for use in diagnostic procedures. The Avantect Pancreatic and Ovarian Cancers Tests are early detection tests. The tests do not establish a diagnosis of pancreatic cancer or ovarian cancer, respectively, and results should be considered in the context of other clinical criteria.

Cancer statistics quoted on this website are taken from the CDC and SEER websites, 2025 data.

©2026 ClearNote Health, All Rights Reserved.

Avantect and Virtuoso are trademarks of ClearNote Health. Other trademarks are the property of their respective owners.

Privacy Policy
Terms of Use
Billing rights & protections
Cookie Preferences